The U.S. Department of Transportation (DOT) has failed to publish rules implementing a Congressionally-mandated auto safety whistleblower program. Senators Richard Blumenthal (D-CT) and Edward Markey (D-MA) sent a letter to Transportation Secretary Pete Buttigieg demanding that the DOT immediately implement the whistleblower program.
“Over the past few years, we have observed increasingly devastating...
Continue reading…
Category: Whistleblower Cases
Securities and Exchange Commission files suit against New Hampshire firm LBRY for failure to register offering of securities LBRY Token
The Securities and Exchange Commission (SEC) has filed a civil suit against New Hampshire firm LBRY because it allegedly failed to register an offering of securities. The SEC Complaint states: "From 2016 through the present, LBRY offered and sold millions of dollars’ worth of unregistered securities to investors, in the form of a digital...
Continue reading…
Securities & Exchange Commission charges trader with fraud for false tweets alleging yield over $900,000 in profits
The Securities and Exchange Commission has issued fraud charges and an asset freeze against a trader who used Twitter to spread false information about a defunct...
Continue reading…
Telemarketers pay $4 million to end case of soliciting patients and paying telemed docs for prescriptions for compounded drugs for kickbacks
Two telemarket company owners Jack Lee Stapleton and Jack Hunter Stapleton will pay $4 million to end allegations they engaging in schemes to generate prescriptions for...
Continue reading…
Psychiatrist sentenced for healthcare fraud in false billing practices
Uzma Ehtesham, a psychiatrist who defrauded Virginia Medicaid and Medicare by fraudulently billing these programs for services not performed, was sentenced yesterday to two years’ probation, six months of which must be spent on home detention. According to court documents, Ehtesham devised a scheme to defraud Virginia Medicaid and Medicare by billing for individual...
Continue reading…
SEC charges AT&T and three execs with selectively providing nonpublic information to research analysts
The Securities and Exchange Commission has charged AT&T, Inc. with repeatedly violating a securities regulation prohibiting disclosure of nonpublic ionformation, and three of its Investor Relations executives with aiding and abetting AT&T's violations, by selectively disclosing material nonpublic information to research analysts.
According to the SEC's complaint, AT&T learned...
Continue reading…
Pharmacy owner and accountant indicted in $134 million health care fraud scheme
The government is alleging that two Houston area men, Mohamed Mokbel and Fathy Elsafty, engaged in a $134 million healthcare fraud scheme. The indictment alleges Mokbel is the owner of several Houston area pharmacies, while Elsafty is his accountant. Mokbel was the CEO of 4M Pharmaceuticals Inc., which was the parent company for several...
Continue reading…
Switzerland’s oldest private bank Rahn & Bodmer pays U.S. $22 million for helping holders file false tax returns defrauding IRS of millions
Rahn & Bodmer, Zurich Switzerland's oldest private bank, will pay $22 million to the U.S. government for conspiring to help U.S. account holders file false federal tax returns and defraud the IRS hiding hundreds of millions of dollars offshore. Rahn & Bodmer helped U.S. account holders file false federal tax returns and commit tax...
Continue reading…
SEC charges AT&T and 3 execs with giving certain Wall street analysts access to nonpublic info without sharing it widely
AT&T and three of its executives have been charged by the SEC with selectively giving some Wall Street analysts access to nonpublic information without sharing it widely. The SEC said that internal documents showed that data was generally considered material to investors and cannot be selectively disclosed under the Fair Disclosure Regulation (Regulation FD)....
Continue reading…
Biotech consultant who advised on Cambridge gene therapy firm Dimension Therapeutics acquisition pleads guilty to insider trading charges
Mark Joseph Ahn, a biotech consultant who advised on Cambridge gene therapy firm Dimension Therapeutics' potential acquisition in 2017 has pleaded guilty to charges of insider trading. He was charged by the U.S. Attorney's Office for...
Continue reading…
